Carlsquare advises the shareholders of CannaCare Health GmbH on an investment from Altitude Investment Management
Carlsquare advises the shareholders of CannaCare Health GmbH (“CannaCare”) in their search for growth capital and the investment from Altitude Investment Management (“Altitude”). CannaCare is a German healthcare start-up and the leading cannabidiol (CBD) brand in Germany, with a variety of own products distributed under “CANOBO”. Altitude is a venture capital firm that specialises in investments in cannabis-related start-ups.
As an already established player in the German CBD market, CannaCare is looking to use the investment received by Altitude in order to expand its offering and brand awareness across Europe. CannaCare will benefit from Altitudes comprehensive know-how and diversified network in the legal cannabis industry. CannaCare is already Altitude‘s third investment in Europe.
CannaCare is the leading German brand for high-quality cannabidiol (CBD) based products. In addition, the Duesseldorf-based start-up is positioning itself as a manufacturer and wholesaler of high-quality CBD products. CannaCare is a fast-growing German healthcare start-up with a strong German footprint.
Altitude specialises in investments in start-ups which are operating in legal cannabis-related industries. Altitude’s current existing portfolio reflects on the diversity in the legal cannabis supply chain – from cultivation to technology to media.
Altitude Investment Management: